Indian drug makers maintain pace of US mktg nod

Twenty five Indian generic drug makers got a little over 200 approvals from the US Food and Drug Administration in 2009, half a dozen more than the number approved in 2008. This increase is despite......

Ranbaxy gets Australia nod for antipsychotic drug

Drug major Ranbaxy on Wednesday said it has received approval from the Australian health regulator to market its antipsychotic drug Ozidal Risperidone in that country. Ranbaxy Australia, the wholly......

Sun Pharma challenges J&J's drug patent

Mumbai-based Sun Pharmaceuticals has filed a post-grant opposition with the Mumbai patent office against a product patent granted to the extended release version of Johnson and Johnson's (J&J)......

Indian pharma prefers non-litigation route in US

The Indian pharmaceutical companies are involved in patent litigations of a mere 40 drugs, out of the 135 known patent litigation drugs in the US. This is despite the claims by major Indian......